循环AMP调节的承诺可以恢复神经发育障碍患者的认知功能
Aniket Bhattacharya1, Luka Turkalj1, M Chiara Manzini1
1Department of Neuroscience and Cell Biology and Child Health Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, 08901, USA.
Current opinion in neurobiology
|December 31, 2024
概括
向二酶4D (PDE4D) 的选择性抑制剂通过恢复认知功能来治疗神经发育和神经退行性疾病具有前景. 这些新型化合物提供了更好的选择性和生理抑制,促进了治疗的发展.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 循环AMP (cAMP) 信号传递对突触功能至关重要,但在神经发育障碍 (NDD) 和神经退行性疾病中受到失调.
- 固酶4D (PDE4D) 调节突触中的cAMP水平,影响神经元可塑性和认知功能.
- PDE4D和cAMP依赖蛋白激酶 (PKA) 的遗传变异与NDD有关.
研究的目的:
- 讨论开发PDE4D选择性全抑制剂的理由.
- 为突出PDE4D抑制剂最近的临床试验进展.
- 探索了解PDE4D功能和抑制剂发展的未来方向.
主要方法:
- 关于cAMP信号,PDE4D功能和抑制剂开发的科学文献的综述.
- 从用新型PDE4D抑制剂治疗的动物模型中分析临床前数据.
- 讨论临床试验结果和治疗潜力.
主要成果:
- 选择性PDE4D抑制剂在临床前模型中显示出改善的认知功能.
- 这些抑制剂提供了增强的选择性和更多的生理酶抑制.
- 最近的临床试验显示了针对PDE4D的向疗法的有希望的结果.
结论:
- 对于NDD和神经退行性疾病来说,PDE4D是一种可行的治疗标.
- 选择性全抑制剂代表了对认知增强的有前途的战略.
- 对PDE4D功能和下一代抑制剂的进一步研究是有必要的.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
95
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
95
Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K
cAMP-dependent Protein Kinase Pathways
6.1K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.1K
Long-term Potentiation
2.7K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
2.7K
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K


